MedPath

Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software

Not Applicable
Completed
Conditions
Cataract
Glaucoma
Interventions
Device: Cornea/Anterior Segment OCT CASIA2
Device: Optovue RTVue XR Avanti
Registration Number
NCT04486976
Lead Sponsor
Tomey Corporation
Brief Summary

This study is a prospective comparative, randomized, single center study to gather agreement and precision data in all subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
134
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
NormalCornea/Anterior Segment OCT CASIA2-
GlaucomaOptovue RTVue XR Avanti-
NormalOptovue RTVue XR Avanti-
GlaucomaCornea/Anterior Segment OCT CASIA2-
CataractOptovue RTVue XR Avanti-
CataractCornea/Anterior Segment OCT CASIA2-
Primary Outcome Measures
NameTimeMethod
Agreement of Angle-Opening Distance (mm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Angle-Opening Distance Angle-Opening Distance

Agreement of Corneal thickness (μm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Thickness of Cornea

Agreement of OCT image quality for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCT and evaluation of visibility of predefined anatomical structuresUp to 30 days
Precision of the Corneal thickness (μm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Corneal thickness

Precision of the Angle-Opening Distance (mm) measurement for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Angle-Opening Distance

Precision of the Ks (steep meridian) measurement (D) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Ks (steep meridian)

Agreement of Trabecular-Iris Space Area measurement (mm²) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Trabecular-Iris Space Area

Precision of the Anterior Corneal Depth measurement (mm) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Anterior Corneal Depth

Precision of the Pupil Diameter measurement (mm) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Pupil Diameter

Precision of the Average Keratometry measurement (D) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Average Keratometry

Precision of the Angle Recess Area measurement (mm²) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Angle Recess Area

Precision of the Kf (flat meridian) measurement (D) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Kf (flat meridian)

Precision of the Anterior Corneal Width measurement (mm) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Anterior Corneal Width

Precision of the Trabecular-Iris Angle measurement (mm) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Trabecular-Iris Angle

Precision of the Trabecular-Iris Space Area measurement (mm²) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Trabecular-Iris Space Area

Precision of the Corneal Cylinder measurement (D) for Cornea/Anterior Segment OCT CASIA2 and Optovue RTVue XR Avanti OCTUp to 30 days

Corneal Cylinder

Secondary Outcome Measures
NameTimeMethod
Adverse EventsUp to 30 days

An adverse event (AE) is defined as any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of an investigational device but not necessarily related to the investigational device.

Trial Locations

Locations (1)

Andover Eye Associates

🇺🇸

Andover, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath